Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ptc Therapeutics (PTCT) Other Working Capital Changes (2016 - 2025)

Ptc Therapeutics (PTCT) has 14 years of Other Working Capital Changes data on record, last reported at $22.9 million in Q4 2025.

  • For Q4 2025, Other Working Capital Changes rose 301.22% year-over-year to $22.9 million; the TTM value through Dec 2025 reached $36.8 million, up 648.79%, while the annual FY2025 figure was $36.8 million, 648.79% up from the prior year.
  • Other Working Capital Changes reached $22.9 million in Q4 2025 per PTCT's latest filing, up from $10.0 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $63.8 million in Q3 2023 and bottomed at -$62.8 million in Q2 2023.
  • Average Other Working Capital Changes over 5 years is $8.5 million, with a median of $9.4 million recorded in 2022.
  • Peak YoY movement for Other Working Capital Changes: crashed 1200.42% in 2021, then surged 2151.06% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at $23.5 million in 2021, then tumbled by 31.81% to $16.0 million in 2022, then soared by 181.89% to $45.1 million in 2023, then plummeted by 87.33% to $5.7 million in 2024, then surged by 301.22% to $22.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Other Working Capital Changes were $22.9 million in Q4 2025, $10.0 million in Q3 2025, and -$12.6 million in Q2 2025.